SKOLD v. GALDERMA LABORATORIES, L.P. et al

Filing 57

MEMORANDUM AND ORDER (REVISED ORDER) THAT DEFENDANT GALDERMA S.A.'S MOTION TO DISMISS THE BREACH OF CONTRACT CLAIM IN COUNT FIVE IS GRANTED; COUNT FIVE OF THE COMPLAINT SHALL BE DISMISSED WITH PREJUDICE AS TO DEFENDANT GALDERMA S.A.; DEFENDANTS& #039; GALDERMA LABORATORIES, INC.'S MOTION TO DISMISS THE UNJUST ENRICHMENT CLAIM IN COUNT SIX IS GRANTED; COUNT SIX OF THE COMPLAINT SHALL BE DISMISSED WITH PREJUDICE AS TO DEFENDANT GALDERMA LABORATORIES, INC.; DEFENDANTS' MOTIONS TO DISM ISS THE UNFAIR COMPETITION CLAIM IN COUNT FOUR ARE GRANTED IN PART; TO THE EXTENT THE PLAINTIFF BASES HIS UNFAIR COMPETITION CLAIM ON THE DEFENDANTS' ALLEGED FAILURE TO REVERT THE TRADEMARK TO HIM BASED ON THE TERMS OF THE PARTIES' AGREEMEN T, THE CLAIM IS DISMISSED WITH PREJUDICE AS TO ALL DEFENDANTS ON THOSE GROUNDS; THE MOTIONS TO DISMISS THIS CLAIM ARE OTHERWISE DENIED; DEFENDANTS' MOTIONS TO DISMISS FOR FAILURE TO STATE A CLAIM ARE OTHERWISE DENIED; DEFENDANTS' MOTIONS TO STAY ARE DENIED AS MOOT; AND DEFENDANT GALDERMA S.A.'S MOTION TO DISMISS FOR LACK OF PERSONAL JURISDICTION IS DENIED. SIGNED BY HONORABLE WENDY BEETLESTONE ON 4/17/15. 4/17/15 ENTERED & E-MAILED.(fdc)

Download PDF
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA THOMAS SKÖLD, Plaintiff, v. CIVIL ACTION GALDERMA LABORATORIES, L.P.; GALDERMA LABORATORIES, INC.; and GALDERMA S.A., Defendants. NO. 14-5280 REVISED ORDER AND NOW, this 17th day of April, 2015, upon consideration of Defendants Galderma Laboratories, L.P. and Galderma Laboratories, Inc.’s Motion to Dismiss and Motion to Stay Pending the Outcome of the Administrative Proceeding [ECF No. 22], Plaintiff Thomas Sköld’s Response in Opposition thereto [ECF No. 29], and Galderma L.P. and Galderma Inc.’s Reply [ECF No. 33]; Defendant Galderma S.A.’s Motion to Dismiss and Motion to Stay Pending the Outcome of the Administrative Proceeding [ECF No. 36], the Plaintiff’s Response in Opposition thereto [ECF No. 38], and Galderma S.A.’s Reply [ECF No. 46]; the parties’ supplemental briefing on the Plaintiff’s unfair competition claim [ECF Nos. 54 & 55]; and oral argument on March 19, 2015, and for the reasons provided in the Court’s revised opinion of April 17, 2015 [ECF No. 56], IT IS ORDERED that: (1) Defendant Galderma S.A.’s motion to dismiss the breach of contract claim in Count Five is GRANTED; Count Five of the Complaint shall be DISMISSED WITH PREJUDICE as to Defendant Galderma S.A.; (2) Defendants’ Galderma Laboratories, Inc.’s motion to dismiss the unjust enrichment claim in Count Six is GRANTED; Count Six of the Complaint shall be DISMISSED WITH PREJUDICE as to Defendant Galderma Laboratories, Inc.; (3) Defendants’ motions to dismiss the unfair competition claim in Court Four are GRANTED IN PART; to the extent the Plaintiff bases his unfair competition claim on the Defendants’ alleged failure to revert the trademark to him based on the terms of the parties’ agreement, the claim is DISMISSED WITH PREJUDICE as to all Defendants on those grounds; the motions to dismiss this claim are otherwise DENIED; (4) Defendants’ motions to dismiss for failure to state a claim are otherwise DENIED; (5) Defendants’ motions to stay are DENIED AS MOOT; and (6) Defendant Galderma S.A.’s motion to dismiss for lack of personal jurisdiction is DENIED. BY THE COURT: /S/WENDY BEETLESTONE, J. ______________________________ WENDY BEETLESTONE, J.

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?